Original Research
Published on 08 Sep 2022
Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
in Vaccines and Molecular Therapeutics

- 3,948 views
- 6 citations














